Oral Tablet
Oral Tablet - Related Videos
11:11
Preparing and Administering Oral Tablet and Liquid Medications
0 Views •
2015
Source: Madeline Lassche, MSNEd, RN and Katie Baraki, MSN, RN, College of Nursing, University of Utah, UT Oral medications are the route most preferred by patients and are one of the most commonly used routes of medication administration by providers. Most oral preparations are taken by mouth, swallowed with fluid, and absorbed via the gastrointestinal tract. Oral medications are available in solid forms (e.g., tablets, capsules, caplets, and enteric-coated tablets) and liquid forms (e.g.,...
10:13
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
0 Views •
Cited by 11 •
2014
We tested the usability of a tablet-computer-based application (EmoCogMeter) in investigating the effects of age on cognition. Results show an age-related cognitive decline, thereby proving the usability of our application. Findings underline the great clinical and practical potential of a tablet-based application for detection and monitoring of cognitive dysfunction.
10:10
Evaluating Tests of Cognition using a Computerized Touch-Sensitive Tablet, Eye Tracking, and Functional Magnetic Resonance Imaging
0 Views •
2026
A protocol for simultaneous recording of visuomotor behavior and brain activity during standard paper-based cognitive tests using an MRI-compatible tablet and eye-tracking technology alongside functional MRI, towards improving the usage of such tests. Preliminary results are presented from a young healthy adult performing a Trail-Making test.
05:44
Formation of Dispersible Taohong Siwu Tablets
0 Views •
2023
This article discusses the process used to formulate and prepare Taohong Siwu, a traditional Chinese medicine, as a dispersible tablet. We performed single-factor and orthogonal experiments to screen the prescription excipients, optimize the formulation process, and produce dispersible Taohong Siwu tablets.
04:28
Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
0 Views •
Cited by 4 •
2016
The following protocol describes a novel method for chronic oral drug administration using an orally dissolving strip (ODS) in lieu of the more commonly used oral gavage method. We demonstrate that preclinical, oral drug delivery using the ODS method represents a safe, convenient, and humane alternative to oral gavage.
FAQs
These stages occur in sequence but represent different events. Gastrointestinal fluids first break the tablet apart, then the active pharmaceutical ingredient dissolves, and the dissolved material becomes available for absorption into the bloodstream. Evaluating each stage helps researchers identify whether a formulation may influence drug availability, therapeutic effectiveness, or the consistency of clinical treatment.
Excipients and compression are formulation variables that can change how a tablet behaves after swallowing. Their combined effects may influence disintegration, stability, release rate, and tolerability. Researchers therefore consider more than the active pharmaceutical ingredient when assessing performance, because the physical design of the dosage form can affect how reliably medication becomes available.
Coatings can modify how the tablet releases its active pharmaceutical ingredient and may also influence tolerability. By changing release behavior, a coating can affect when medication becomes available after swallowing. This makes coating selection relevant to formulation development and to research examining whether a tablet provides the intended release pattern in clinical use.
Stability and release rate depend on formulation features including excipients, compression, and coatings. These elements can be adjusted or evaluated as part of tablet development because they influence how the dosage form performs in gastrointestinal fluids. Understanding their effects helps researchers connect physical formulation characteristics with medication availability and the intended clinical outcome.
Clinical evaluation can examine bioavailability, therapeutic effectiveness, and patient adherence. Bioavailability addresses how the active ingredient becomes available for absorption, while therapeutic effectiveness concerns the resulting treatment performance. Adherence reflects whether patients can follow the dosing approach in practice. Together, these outcomes provide a broader assessment than laboratory release behavior alone.
Oral tablets support dosing in both acute and chronic care, so their clinical value extends across short-term and ongoing treatment. Convenience can assist routine medication use, while formulation choices may address release rate and tolerability. Researchers also examine adherence because the practical success of a tablet depends partly on how consistently patients can follow the prescribed dosing approach.
Controlled-release research focuses on formulation features that regulate how quickly the active pharmaceutical ingredient becomes available. Investigators can relate release behavior to bioavailability, therapeutic effectiveness, and tolerability to determine whether the intended delivery pattern is achieved. These studies are clinically relevant because release control may support medication use across different treatment settings and dosing needs.